Advertisement
Selected Topics: Toxicology| Volume 57, ISSUE 4, e109-e111, October 2019

Accidental Pediatric Paliperidone Ingestion Resulting in Delayed Profound Tachycardia

  • Heather A. Borek
    Correspondence
    Reprint Address: Heather Borek, md, Division of Medical Toxicology, Department of Emergency Medicine, University of Virginia School of Medicine, 1222 Jefferson Park Ave, 4th Floor, Charlottesville, VA 22908.
    Affiliations
    Division of Medical Toxicology, Department of Emergency Medicine, University of Virginia School of Medicine, Charlottesville, Virginia
    Search for articles by this author
  • Nathan P. Charlton
    Affiliations
    Division of Medical Toxicology, Department of Emergency Medicine, University of Virginia School of Medicine, Charlottesville, Virginia
    Search for articles by this author

      Abstract

      Background

      Paliperidone is an atypical antipsychotic that is approved to treat schizophrenia in patients 12 years of age and older. There are minimal data on the clinical effects of exposure in the < 12-year-old age group.

      Case Report

      We report the case of a 7-year-old girl who was accidentally dosed with paliperidone for 3 days. Her clinical course was notable for a dystonic reaction and profound sinus tachycardia, with a heart rate peaking at 201 beats/min. The tachycardia persisted for over 64 h after her last dose. The mechanism of tachycardia has not been elucidated and is likely multifactorial, with alpha blockade and anticholinergic effects probably contributing.

      Why Should an Emergency Physician Be Aware of This?

      Clinicians should be aware that paliperidone ingestion in children may result in delayed, profound tachycardia and may require more prolonged observation times or admission to the hospital.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Emergency Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Tsay M.E.
        • Klein-Schwartz W.
        • Anderson B.
        Toxicity and clinical outcomes of paliperidone exposures reported to U.S. Poison Centers.
        Clin Toxicol (Phila). 2014; 52: 207-213
      1. Invega (paliperidone) extended-release tablets [package insert]. Pharmaceuticals, Inc., Titusville, NJ2007 (revised 7/2017)
        • Levine M.
        • Lovecchio F.
        • Tafoya P.
        • Graham R.
        Paliperidone overdose with delayed onset of toxicity.
        Ann Emerg Med. 2011; 58: 80-82
        • Wong L.Y.
        • Greene S.L.
        • Odell M.
        • Wong K.
        Severe prolonged posture-evoked tachycardia after massive overdose of paliperidone.
        Clin Toxicol (Phila). 2016; 54: 535
        • Acri A.A.
        • Henretig F.M.
        Effects of risperidone in overdose.
        Am J Emerg Med. 1998; 16: 498-501